QuidelOrtho Corporation Announces Secondary Offering of Common Stock by the Carlyle Group
QuidelOrtho Corporation (QDEL)
Last quidelortho corporation earnings: 2/12 04:10 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.quidel.com
Company Research
Source: Business Wire
SAN DIEGO--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today the launch of an underwritten secondary offering (the “Offering”) by Carlyle Partners VI Cayman Holdings, L.P. (the “Selling Stockholder”) of 8,260,183 shares of the Company’s common stock (“Common Stock”).The Selling Stockholder will receive all of the proceeds from the Offering. The Company is not selling any shares of Common Stock in the Offering and will not receive any proceeds from the Offering.The last reported sale price of QuidelOrtho’s Common Stock on November 19, 2024 was $38.58 per share. Goldman Sachs & Co. LLC is acting as the sole underwriter of the Offering.The underwriter proposes to offer the shares of Common Stock to the public at a fixed price, which may be changed at any time without notice.Following the
Show less
Read more
Impact Snapshot
Event Time:
QDEL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
QDEL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
QDEL alerts
High impacting QuidelOrtho Corporation news events
Weekly update
A roundup of the hottest topics
QDEL
News
- QuidelOrtho Co. (NASDAQ: QDEL) had its "market perform" rating re-affirmed by analysts at William Blair.MarketBeat
- QuidelOrtho Corporation Announces Pricing of Secondary Offering of Common Stock by the Carlyle GroupBusiness Wire
- In Vitro Diagnostics (IVD) Market to Reach USD 126.6 Billion by 2032, at 4.8% CAGR, Driven by Rising Prevalence of Chronic Diseases and Advances in Diagnostic Technologies – S&S Insider [Yahoo! Finance]Yahoo! Finance
- Kuehn Law Encourages Investors of QuidelOrtho Corporation to Contact Law FirmPR Newswire
- QuidelOrtho Stock Rises as Q3 Earnings & Revenues Beat Estimates [Yahoo! Finance]Yahoo! Finance
QDEL
Earnings
- 11/7/24 - Beat
QDEL
Sec Filings
- 11/22/24 - Form 3
- 11/21/24 - Form SC
- 11/21/24 - Form 4
- QDEL's page on the SEC website